General Information of the Compound
| Compound ID |
CP0480272
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-methyl-5-[2-methyl-4-(1,3,5-trimethylpyrazol-4-yl)phenyl]-N-[(3-phenylimidazo[1,2-a]pyridin-6-yl)methyl]-1,3,4-oxadiazol-2-amine
Show/Hide
|
||||||||||||||||||
| Formula |
C30H29N7O
|
||||||||||||||||||
| Molecular Weight |
503.61
|
||||||||||||||||||
| Canonical SMILES |
CN(Cc1ccc2ncc(-c3ccccc3)n2c1)c1nnc(o1)-c1ccc(cc1C)-c1c(C)nn(C)c1C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29N7O/c1-19-15-24(28-20(2)34-36(5)21(28)3)12-13-25(19)29-32-33-30(38-29)35(4)17-22-11-14-27-31-16-26(37(27)18-22)23-9-7-6-8-10-23/h6-16,18H,17H2,1-5H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
PMJJGXAEXZHYMI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT01661, Tyrosine-protein kinase receptor TYRO3
Protein ID: PT01128, Tyrosine-protein kinase receptor UFO